Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest International AIDS Vaccine Initiative Stories

2012-09-12 10:25:24

Vaccine research integral to ending AIDS pandemic BOSTON, MA, Sept. 12, 2012 /CNW/ - Government of Canada delegates joined researchers, clinicians, private sector partners and public health experts in Boston, September 9-12, 2012, to work towards advancing HIV vaccine science at the AIDS Vaccine 2012 conference, the largest and most diverse meeting of its kind. "Developing a globally accessible HIV vaccine is a priority for our government," said federal Health Minister, Leona...

2012-08-20 10:23:47

MVI, International AIDS Vaccine Initiative, and Imperial College London Establish Collaboration to Guide Selection and Prioritization of Malaria Vaccine Candidates WASHINGTON, Aug. 20, 2012 /PRNewswire-USNewswire/ -- In response to a critical gap in developing malaria vaccines, the PATH Malaria Vaccine Initiative (MVI) announced a new collaboration today with the International AIDS Vaccine Initiative (IAVI) and Imperial College London to measure the capacity of different vaccine...

2012-07-23 02:25:38

Report released at AIDS 2012 calls for sustained funding of HIV prevention research to achieve our collective vision of zero new HIV infections WASHINGTON, July 23, 2012 /PRNewswire-USNewswire/ -- A decade of unprecedented investment in HIV prevention research has led to major scientific breakthroughs in vaccines, microbicides, voluntary medical male circumcision, treatment as prevention and pre-exposure prophylaxis, or PrEP, but sustained financing will be needed to capitalize on these...

2012-07-18 06:27:44

RESTON, Va. and GENEVA, July 18, 2012 /PRNewswire-USNewswire/ -- Clinical Care Options (CCO), a leader in next-generation medical education, information, and publishing for healthcare professionals, will provide official online scientific analysis of the XIX International AIDS Conference (AIDS 2012) in Washington, DC, July 22-27, 2012. "The International AIDS Conference represents the premier biennial gathering for all those working in the HIV field. Thanks to recent scientific advances, we...

2012-05-15 10:25:21

WASHINGTON, May 15, 2012 /PRNewswire-USNewswire/ -- Skyrocketing rates of HIV among African Americans and Latinos in the Bay Area will take center stage when national and local leaders in HIV policy convene in San Francisco on May 23-24 for a conference on the unequal burden of HIV/AIDS among communities of color, sexual minorities and the poor. Sponsored by the Washington-based Forum for Collaborative HIV Research, the meeting comes at a time when HIV infection among African Americans is...

2012-05-10 06:21:09

CLEVELAND, May 10, 2012 /PRNewswire/ -- What makes a Grand Challenge grand? Consider the complexities of curing breast cancer, purging greenhouse gases from the atmosphere, launching civilian spacecraft, or eradicating the devastating AIDS pandemic. These are the kinds of problems that require an amplified approach to open innovation, or "connecting with the world" to find new solutions. Combining this approach with public messaging, marketing and social networking is the hallmark of a Grand...

2012-04-09 09:44:14

Global Health R&D Forum convenes global health advocates, researchers and industry leaders New York voters recognize the importance of global health research and are concerned about the United States' ability to compete globally, according to a new poll commissioned by Research!America, yet an overwhelming majority (93%) of those polled don't know where global health research is conducted in their own state. The majority of New Yorkers (64%) think that New York residents should be...

2012-03-27 06:23:51

CLEVELAND, March 27, 2012 /PRNewswire/ -- Innovators live at all levels of organizations, and often run companies of their own. These are the brilliant minds that NineSigma taps to solve the biggest, most perplexing challenges in the world, from developing an effective AIDS vaccine to making electricity accessible in developing countries. In addition, as more businesses commit to innovation as a growth strategy, new doors are opening for entrepreneurs, inventors and researchers...

2012-03-20 02:24:37

ATLANTA, March 20, 2012 /PRNewswire/ -- GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, announced today that it has entered into definitive agreements with certain institutional investors, pursuant to which the Company has agreed to sell shares of its Series A convertible preferred stock at an aggregate purchase price of approximately $2.2 million (which are...

2012-03-07 11:30:00

ATLANTA, March 7, 2012 /PRNewswire/ -- Harriet L. Robinson, Ph.D., Chief Scientific Officer at GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), a biotech company specializing in the development of HIV/AIDS vaccines, announced the results of a study suggesting that scientists may be one step closer to a vaccine that protects against multiple exposures to HIV infections. The study results were unveiled by Dr. Robinson during a presentation in Seattle at the 2012 Conference on...